Regenxbio (RGNX) EBIT Margin Growth (1y) (2015 - 2025)
Regenxbio (RGNX) EBIT Margin Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn | 2,984.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,984.00 |
| Sep 30, 2025 | 8,028.00 |
| Jun 30, 2025 | -3,975.00 |
| Mar 31, 2025 | 43,014.00 |
| Dec 31, 2024 | 4,554.00 |
| Sep 30, 2024 | -3,189.00 |
| Jun 30, 2024 | 10,945.00 |
| Mar 31, 2024 | -7,052.00 |
| Dec 31, 2023 | -10,338.00 |
| Sep 30, 2023 | 4,331.00 |
| Jun 30, 2023 | -17,443.00 |
| Mar 31, 2023 | -2,375.00 |
| Dec 31, 2022 | -26,297.00 |
| Sep 30, 2022 | -8,161.00 |
| Jun 30, 2022 | 4,548.00 |
| Mar 31, 2022 | -8,871.00 |
| Dec 31, 2021 | 32,884.00 |
| Sep 30, 2021 | -20,046.00 |
| Jun 30, 2021 | 1,551.00 |
| Mar 31, 2021 | -1,955.00 |